2012 Deep Research Report on Global and China Synthesis Polypeptide Drug Industry

2012 Deep Research Report on Global and China Synthesis
Polypeptide Drug Industry
Report Details:
Published:September 2012
No. of Pages: 305
Price: Single User License – US$2400

2012 Deep Research Report on Global and China Synthesis Polypeptide Drug Industry was
professional and depth research report on China Synthesis Polypeptide Drug industry. The report
firstly introduced Synthesis Polypeptide Drug basic information included Synthesis Polypeptide
Drug definition classification application industry chain structure industry overview; international
market analysis, China domestic market analysis, Macroeconomic environment and economic
situation analysis and influence, Synthesis Polypeptide Drug industry policy and plan, Synthesis
Polypeptide Drug product specification, manufacturing process, product cost structure etc. then
statistics China key manufacturers Synthesis Polypeptide Drug capacity production cost price
profit production value gross margin etc details information, at the same time, statistics these
manufacturers Synthesis Polypeptide Drug products customers application capacity market
position company contact information etc company related information, then collect all these
manufacturers data and listed China Synthesis Polypeptide Drug capacity production capacity
market share production market share supply demand shortage import export consumption etc
data statistics, and then introduced China Synthesis Polypeptide Drug 2009-2013 capacity
production price cost profit production value gross margin etc information. And also listed
Synthesis Polypeptide Drug upstream raw materials equipments and Sharp Solarnstream clients
alternative products survey analysis and Synthesis Polypeptide Drug marketing channels industry
development trend and proposals. In the end, this report introduced Synthesis Polypeptide Drug
new project SWOT analysis Investment feasibility analysis investment return analysis and also
give related research conclusions and development trend analysis of China Synthesis Polypeptide
Drug industry. In a word, it was a depth research report on China Synthesis Polypeptide Drug
industry. And thanks to the support and assistance from Synthesis Polypeptide Drug industry
chain related technical experts and marketing engineers during Research Team survey and
interviews.

Get your copy of this report @
http://www.reportsnreports.com/reports/190930-2012-deep-research-report-on-global-and-china-synthesis-
polypeptide-drug-industry.html

Major points covered in Table of Contents of this report include
Table of Contents

Chapter One Synthesis Polypeptide Drug Industry Overview 1
1.1 Synthesis Polypeptide Drug Definition 1
1.2 Synthesis Polypeptide Drug Classification and Application 3
1.3 Professional Terms Interpretation 8
1.4 Synthesis Polypeptide Drug Industry Chain Structure 12
1.5 Synthesis Polypeptide Drug Industry Overview 14

Chapter Two Synthesis Polypeptide Drug International and China Market Analysis 16
2.1 Synthesis Polypeptide Drug Industry International Market Analysis 16
2.1.1 Synthesis Polypeptide Drug International Market Development History 16
2.1.2 Synthesis Polypeptide Drug Product and Technology Developments 18
2.1.3 Synthesis Polypeptide Drug Competitive Landscape Analysis 25
2.1.4 Synthesis Polypeptide Drug International Key Countries Development Status 28
2.1.5 Synthesis Polypeptide Drug International Market Development Trend 30
2.2 Synthesis Polypeptide Drug China Market Analysis 33
2.2.1 Synthesis Polypeptide Drug China Market Development History 33
2.2.2 Synthesis Polypeptide Drug Product and Technology Developments 33
2.2.3 Synthesis Polypeptide Drug Competitive Landscape Analysis 35
2.2.4 Synthesis Polypeptide Drug China Key Regions Development Status 37
2.2.5 Synthesis Polypeptide Drug China Market Development Trend 37
2.3 Synthesis Polypeptide Drug International and China Market Comparison Analysis 42

Chapter Three Major Synthesis Polypeptide Drug Analysis 43
3.1 Immunity Regulating Medicine (Allergy Infection and Immune) 43
3.1.1 Glatiramer Injection (Glatiramer Acetate) 43
3.1.2 Thymalfasin for Injection 46
3.1.3 Thymopentin Injection 49
3.1.4 Thymopetidum Injection 53
3.1.5 Summary 55
3.2 Digestive System Drugs (Gastrointestinal Type) 57
3.2.1 Octreotide Acetate Injection 57
3.2.2 Somatostatin for Injection 61
3.3 Bone and Connective Tissue Types (Thyroid hormones Drug) 66
3.3.1 Salmon Calcitonin Injection 67
3.3.2 Elcatonin Injection 70
3.3.4 TerfparaLide Injectlon 72
3.4 Gynecologic or Obstetric Drug 76
3.4.1 Oxytocin Injection 76
3.4.2 Carbetocin Injection 81

3.4.3 Acetate Atosiban Injection 83
3.5 Tumor Drug (hCG) 86
3.5.1 Leuprorelin Acetate Microspheres for Injection 87
3.5.2 Goserelin Acetate 89
3.5.3 Triptorelin Acetate Injection 92
3.5.4 Chorionic Gonadotrophin for Injection 95
3.6 Urinary System Drug (Diabetes Insipidus) 98
3.6.1 Desmopressin Acetate Injection 98
3.6.2 Terlipressin for Injection 101
3.7 Metabolic Drug (Insulin and Other Hypoglycemic Agents) 105
3.7.1 Biosynthetic Glucagon for Injection 105
3.7.2 Exenatide Injection 106

Chapter Four Synthesis Polypeptide Drug Development Environmental Analysis 109
4.1 China's Macroeconomic Environment Analysis 109
4.1.1 China GDP Analysis 109
4.1.2 China CPI Analysis 111
4.2 European Economic Environmental Analysis and Impact 113
4.3 United States Economic Environmental Analysis and Impact 116
4.4 Japan Economic Environmental Analysis and Impact 119
4.5 Global Economic Environmental Analysis and Impact 120
4.5.1 Global Economic Environmental Analysis 120
4.5.2 Global Economic Influence 121

Chapter Five Synthesis Polypeptide Drug Development Policy and Plan 121
5.1 China Government Policy and Development Plan 121
5.2 Industry Policy and Standard 122
5.3 Technical Standard 125
5.4 Technology Replacement and R&D Trends 126
5.5 Hotspots and Influence 127

Chapter Six Synthesis Polypeptide Drug Manufacturing Process and Cost Structure 132
6.1 Synthesis Polypeptide Drug Manufacturing Process Overview 132
6.2 Synthesis Polypeptide Drug Manufacturing Process Analysis 135
6.3 Synthesis Polypeptide Drug Cost Structure Analysis 138

Chapter Seven 2009-2013 Synthesis Polypeptide Drug Productions Supply Sales Demand
Market Status and Forecast 140
7.1 2009-2013 Synthesis Polypeptide Drug Capacity Production Overview 140
7.1.1 2009-2013 Global and China Synthesis Polypeptide Drug Capacity Production 140
7.1.2 2009-2013 Synthesis Polypeptide Drug Production Market Share 146
7.1.3 2009-2013 Synthesis Polypeptide Drug Demand Overview 152

7.1.4 2009-2013 Synthesis Polypeptide Drug Supply Demand and Shortage 152
7.1.5 2009-2013 Synthesis Polypeptide Drug Production Import Export Consumption 153
7.1.6 2009-2013 Synthesis Polypeptide Drug Cost Price Production Value Gross Margin 154
7.2 Different Type Synthesis Polypeptide Drug Sales and Market Scale Analysis 156
7.2.1Thymopentin Injection 156
7.2.2 Thymalfasin Injection 158
7.2.3 Calcitonin Injection 159
7.2.4 Somatostatin for Injection 161
7.2.5Octreotide Acetate Injection 162
7.2.6 Desmopressin Acetate Injection 163
7.3 Synthesis Polypeptide Drug Market Summary 165

Chapter Eight Synthesis Polypeptide Drug Key Manufacturers 170
8.1 Novartis 170
8.2 Merck Serono 176
8.3 Ferring Pharmaceuticals 181
8.4 Ipsen PHarma Biotech 188
8.5 Lilly 191
8.6Asahi Kasei 195
8.7 AstraZeneca 199
8.8 SciClone Pharmaceuticals 203
8.9 Takeda 206
8.10 HYBIO Pharmaceutical Co.,Ltd (Shenzhen Stock:300199) 210
8.11 Hainan Zhonghe Pharmaceutical Co.,Ltd 215
8.12 Sichuan Chengdu Diao Pharmaceutical Group Co.,Ltd 219
8.13 Beijing Yingu Century Pharmaceutical Co.,Ltd (Beijing Shiqiao Bio-Pharmaceutical Co.,Ltd)
224
8.14 Hainan Shuangcheng Pharmaceuticals Co.,Ltd 227
8.15 Livzon Pharmaceuticals Co.,Ltd (Livzon:000513) 234
8.16 Wuhan Hualong Bio-Chemical Pharmaceutical Co.,Ltd 238
8.17 Chengdu Tiantaishan Pharmaceutical Co.,Ltd 242
8.18 Beijing Shuanglu Pharmaceutical Co.,Ltd 250
8.19 Yangzijiang Pharmaceutical Co.,Ltd 257
8.20 Changzhou Siyao Pharmaceutical Co.,Ltd 262

Chapter Nine Up and Down Stream Industry Analysis and Influence 267
9.1 Upstream Raw Materials Price Analysis and Influence 267
9.1 Upstream Equipments Market Analysis and Influence 269
9.3 Downstream Demand Analysis and Influence 270
9.4 Industry Policy Analysis and Influence 271

Chapter Ten Synthesis Polypeptide Drug Marketing Channels Analysis 272

10.1 Synthesis Polypeptide Drug Marketing Channels Status 272
10.1.1 Drugs Marketing Channel Developemnt History 272
10.1.1 Prescription Drug Marketing Development Status 273
10.2 Synthesis Polypeptide Drug Marketing Channels Management 274
10.3 Synthesis Polypeptide Drug Marketing Channels Establishment 275
10.4 Synthesis Polypeptide Drug Marketing Channels Development Trend 276

Chapter Eleven Synthesis Polypeptide Drug Industry Development Trend 278
11.1 2012-2016 Synthesis Polypeptide Drug Industry Development Trend 278
11.2 2012-2016 Market Potential Forecast 279
11.3 2012-2016 R&D Trend 280
11.3.1Polypeptide Drug Technical Development Status 280
11.3.2 Polypeptide Drug and Health Care Products Research and Manufacturing Overview 282
11.3.3 China Polypeptide Drug Development Direction and Prospect 283
11.4 2012-2016 Marketing Channels Change Trend 285
14.4.1 Prescription Drug Marketing Channels Change Trend 285
14.4.2 Prescription Drug Sales Method Five Trend 286
11.5 2012-2016 Competition Pattern Development Trends 288

Chapter Twelve Synthesis Polypeptide Drug Industry Development Proposals 289
12.1 Macroeconomic Development Countermeasures 289
12.2 New Firms Enter Market Strategy 290
12.2.1 New Business Entry Barriers 290
12.2.2 New Corporate Strategy 290
12.3 New Project Investment Proposal 293
12.4 Marketing Channel Strategy Proposals 294
12.5 Competitive Environment Strategy Proposals 296
12.5.1 Competitive Environment Analysis 296
12.5.2 Strategy Proposals 297

Chapter Thirteen Synthesis Polypeptide Drug New Project Investment Feasibility Analysis 300
13.1 Synthesis Polypeptide Drug Project SWOT Analysis 300
13.2 Synthesis Polypeptide Drug New Project Investment Feasibility Analysis 302
13.2.1 Buildings 302
13.2.2 Investment 303
13.2.3 Project Schedule 303
13.2.4 Project Investment Return and Feasibility Analysis 304

Chapter Fourteen Synthesis Polypeptide Drug Industry Research Conclusions 304

List Of Tables and Figures

Figure Synthesis Polypeptide Process Flow 1
Figure Synthesis Polypeptide Drug Picture-Thymopentin Injection 2
Figure Polypeptide Applications on Health Care Food and Cosmetics Fields 4
Figure Polypeptide Drug Manufacturing Process Method 4
Table Synthesis Polypeptide Drug Classification and Application List 5
Table Synthesis Polypeptide Drug Product Name Use and Annual Sales Revenue (USD) List 6
Table Listed Polypeptide Drug Name Type Indication 6
Figure Pharmaceutical Industry Value Chain Structure 12
Figure Pharmaceutical Industry Industry Chain Structure 12
Figure Synthesis Polypeptide Drug Industry Chain Structure 13
Figure Synthesis Polypeptide Drug Industrialization System 13
Figure 2000-2011 China Pharmaceutical Industry Sales Revenue and Total Profit (100 Million
RMB) and Growth Rate 14
Figure 2007-2015 China Synthesis Polypeptide Drug Market Scale (100 Million RMB) and Growth
Rate 15
Figure DNA Transcribed into RNA Diagram 17
Figure RNA Translated into Polypeptide Chains Molecular Diagram 18
Table Polypeptide Drug Three Manufacturing Methods 19
Figure 1984 Chemistry Nobel Prize Winner Robert Bruce Merrifield 20
Figure Polypeptide Solid Phase Synthesis Principle 20
Figure Solid Phase Polypeptide Synthesis 21
Figure United States CS Three Channel Full Automatic Polypeptide Synthetic Instrument 22
Figure Homemade CS136 Model Research Polypeptide Synthetic Instrument 23
Figure Large Scale Liquid Phase Synthesis of Polypeptide 24
Figure Thin Film Evaporator (for perishable goods Concentration) 24
Table Global 2008 Revenue More than 1 Billion Polypeptide Drug Brands List 25
Table Some Listed Polypeptide Drug Indication Classification 26
Figure Listed Polypeptide Drug Indication Classification Market Share 26
Figure 2004-2014 Global Pharmaceutical Sales Revenue (Billion USD) and Growth Rate 30
Figure 2009-2013 International Synthesis Polypeptide Drug Market Scale (100 Million RMB) and
Growth Rate 31
Table 2011 Some Polypeptide Drug Global Sales Revenue (100 Million USD) 31
Figure Each Year Enter Clinical Research Polypeptide Drug Quantity (Piece) 32
Table 17 Emerging Pharmaceutical Market Sizes (Billion USD) 38
Figure 2007-2015 China Pharmaceutical Sales Revenue (100 Million USD) 39
Figure 2009-2015 China Polypeptide Drug Market Scale (100 Million RMB) and Growth Rate 39
Figure 2009-2015 China Chemical Synthesis Polypeptide Drug Market Scale (100 Million RMB)
and Growth Rate 40
Figure 2009-2015 China Chemical Synthesis Polypeptide Drug Market Scale (100 Million RMB)
and Proportion of China Total Polypeptide Drug Market Scale 41
Figure 2007-2009 China Chemical Synthesis Polypeptide Drug Types Market Share 41
Table Copaxone Neuron Structure Diagram 44

Table Thymalfasin for Injection (Thymalfasin a1) Suppliers List 48
Table 2010 Thymalfasin for Injection Key Products Price (RMB/Piece) List 49
Table Some Thymopentin Injection Suppliers List 51
Table Thymopentin Injection Hospital Purchase Price (RMB/Piece) List 52
Table Thymopetidum Injection Thymopentin Injection Thymalfasin Injection Comparison 56
Table Octreotide Acetate Injection Key Suppliers List 59
Table 2012 Hebei Province Octreotide Acetate Injection Bid Price List 60
Tale Somatostatin for Injection Key Suppliers List 64
Table Somatostatin for Injection Key Products Hospital Average Purchae Price List 64
Table 2012 Hebei Province Somatostatin for Injection Key Suppliers List 65
Table Salmon Calcitonin Injection Suppliers List 69
Table Salmon Calcitonin Injection/Nasal Spray Products Hospital Purchase Price List 69
Table Salmon Calcitonin Injection/Nasal spray Products Retail Price List 70
Table Elcatonin Injection Key Suppliers and Product Selling Price List 72
Figure TerfparaLide Injectlon—Forsteo Injection Pen Parts 75
Table 2011Q1 China Some Aproved New Drug Number, Specifications Suppliers and Indication
76
Table 2012 New Add Key Monitoring Drug Table--TerfparaLide Injectlon 76
Table Oxytocin Injection Key Suppliers List 78
Table Oxytocin Injection Suppliers Products Models List 80
Table Carbetocin Injection Suppliers List 83
Table Acetate Atosiban Injection Supplier Product Specification Price List 85
Table Leuprorelin Acetate Microspheres for Injection Suppliers Product Specification Price List
88
Table Triptorelin Acetate Injection Suppliers Product Specification Price List 94
Table Chorionic Gonadotrophin for Injection Suppliers Product Specifications List 97
Table 2011 Some Hormone Drugs Independent Pricing and Uniform Pricing Comparison 98
Table Desmopressin Acetate Injection Key Suppliers List 100
Table Desmopressin Acetate Injection Key Suppliers Forms Product Specifications and Bid Price
List 101
Table Terlipressin for Injection Key Brands Manufacturers and Retail Prices 104
Table Biosynthetic Glucagon for Injection Suppliers and Retail Prices List 106
Table Exenatide Suppliers Product Specifications Retail Prices List 109
Figure 2007-2015 China Medical Industry Total Production Value (100 Million RMB) and Growth
Rate 110
Table 2006-2011 China GDP (1000 Million RMB) and Growth Rate 110
Figure 2007-2011 China Medical Industry Total Value and Its Proportion of China Total GDP 111
Figure 2007-2015 China Individual Medical Expenditure (RMB) 112
Figure 2007-2015 China Health Expenditure Per Capita and National Medical Expenditure
Comparison 112
Figure 2011-2016 China Population Growth and Aging Condition 113
Figure 2006-2011 Europe Several Countries PMI Trend 114

Figure United States CPI and PCE Growth Comparison 117
Figure United States Private Savings Rate Change and Net Export /GDP Proportion Change
Trend 118
Figure United States Public Debt and Deficit Proportion of GDP 119
Figure Japan GDP and CPI Growth Rate Comparison 119
Figure 2009-2011 China Health Capital Investment (100 Million RMB) 122
Table China Pharmaceutical Industry All major Departments and Regulatory Functions 122
Table Pharmaceutical Industry main Laws and Regulations and Policies 125
Table 2009-2012 China Medical and Health System Reform Important Policy 128
Table 2009-2012 China Related Pharmaceutical Product Quality Supervision Policy 129
Table 2008-2012 China Development and Reform Commission Policy on Drug Price Management
Policies 130
Figure PTIPolypeptide Synthetic Instruments Picture 133
Table Synthesis Polypeptide Drug Technology Processes List 133
Figure Polypeptide Pharmaceutical Raw Materials Manufacturing Process Flow 135
Figure Freeze Dried Powder Injection Manufacturing Process Flow 136
Figure Small Capacity Injection Manufacturing Process Flow 136
Figure Thymalfasin API Manufacturing Process Flow 137
Figure Thymalfasin Injection Manufacturing Process Flow 138
Figure International Synthesis Polypeptide Drug Cost Structure 139
Table 2009-2011 China Synthesis Polypeptide Drug Cost Structure 139
Table 2009-2013 Global Key Manufacturers Synthesis Polypeptide Drug Capacity and Total
Capacity (10K Piece) List 140
Table 2009-2013 Global Key Manufacturers Synthesis Polypeptide Drug Capacity Market Share
List 140
Table 2009-2013 Global Key Manufacturers Synthesis Polypeptide Drug Production and Total
Production (10K Piece) List 141
Table 2009-2013 Global Key Manufacturers Synthesis Polypeptide Drug Production Market Share
List 141
Table 2009-2013 China Key Manufacturers Synthesis Polypeptide Drug Capacity and Total
Capacity (10K Piece) List 142
Table 2009-2013 China Key Manufacturers Synthesis Polypeptide Drug Capacity Market Share
List 142
Table 2009-2013 China Key Manufacturers Synthesis Polypeptide Drug Production and Total
Production (10K Piece) List 143
Table 2009-2013 China Key Manufacturers Synthesis Polypeptide Drug Production Market Share
List 143
Figure 2009-2013 Global Synthesis Polypeptide Drug Capacity Production (10K Piece) and
Growth Rate 144
Table 2009-2013 Global Synthesis Polypeptide Drug Capacity Utilization Rate List 144
Figure 2009-2013 China Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth
Rate 145

Table 2009-2013 China Synthesis Polypeptide Drug Capacity Utilization Rate List 145
Table 2009-2013 Key Manufacturers Synthesis Polypeptide Drug China Sales (10K Piece) Top20
List 146
Table 2009-2013 Key Manufacturers Synthesis Polypeptide Drug China Sales Top20 Market
Share List 147
Table 2010 Key Manufacturers Synthesis Polypeptide Drug China Sales Revenue (100 Million
RMB) Top10 List 147
Table 2008-2010 Key Manufacturers Synthesis Polypeptide Drug China Sales Revenue Top10
Market Share List 148
Figure 2011 Key Manufacturers Synthesis Polypeptide Drug China Sales Market Share 149
Figure 2012 Key Manufacturers Synthesis Polypeptide Drug China Sales TOP20 Market Share
150
Figure 2011 China Key Manufacturers Synthesis Polypeptide Drug Production Market Share 151
Figure 2012 China Key Manufacturers Synthesis Polypeptide Drug Production Market Share 151
Table 2009-2013 Global Synthesis Polypeptide Drug Demand (10K Piece) and Growth Rate 152
Table 2009-2013 China Synthesis Polypeptide Drug Demand (10K Piece) and Growth Rate 152
Table 2009-2013 China Synthesis Polypeptide Drug Supply Demand and Shortage (10K Piece)
153
Table 2009-2013 Nine Foreign Enterprises Synthesis Polypeptide Drug China Sales (10K Piece)
List 153
Table 2009-2013 China Synthesis Polypeptide Drug Production Import Export Consumption (10K
Piece) List 154
Table 2007-2009 China Synthesis Polypeptide Drug Price (RMB/Piece) Distribution 154
Table 2009-2011 Hainan Shuangcheng Pharmaceuticals Some Synthesis Polypeptide Drug Price
Cost (RMB/Piece) Gross Margin List 155
Table 2009-2013 China Synthesis Polypeptide DrugProduction (10K Piece) Price Cost Gross
(RMB/Piece) Production Value (10K RMB) Gross Margin List 155
Figure 2011 China Synthesis Polypeptide Drug Market Share by Different Type Drug 156
Figure 2008-2014 China Thymopentin Injection Market Scale (100 Million RMB) and Growth
Rate 157
Figure 2008-2014 China Thymopentin Injection Sales (10K Piece) and Growth Rate 157
Figure 2008-2014 China Thymalfasin Injection Market Scale (100 Million RMB) and Growth Rate
158
Figure 2008-2014 China Thymalfasin Injection Sales (10K Piece) and Growth Rate 159
Figure 2008-2014 China Calcitonin Injection Market Scale (100 Million RMB) and Growth Rate
160
Figure 2008-2014 China Calcitonin Injection Sales (10K Piece) and Growth Rate 160
Figure 2008-2014 China Somatostatin for Injection Market Scale (100 Million RMB) and Growth
Rate 161
Figure 2008-2014 China Somatostatin for Injection Sales (10K Piece) and Growth Rate 162
Figure 2008-2014 China Octreotide Acetate Injection Market Scale (100 Million RMB) and Growth
Rate 163

Figure 2008-2014 China Octreotide Acetate Injection Sales (10K Piece) and Growth Rate 163
Figure 2008-2014 China Desmopressin Acetate Injection Market Scale (100 Million RMB) and
Growth Rate 164
Figure 2008-2014 China Desmopressin Acetate Injection Sales (10K Piece) and Growth Rate
164
Table 2009-2011 China Chemical Synthesis Polypeptide Drug Injection Distribution List 165
Figure 2010 Global Polypeptide Drug Market Structure by Treatment Class 165
Table Research or Listed Polypeptide Drugs List 166
Figure 1990-2010 China Resident Three Types of Chronic Disease Prevalence (1/100K) Change
Trend 167
Figure 2010 China Synthesis Polypeptide Drug Hospital Terminal Sales Market Share
Distribution 168
Figure 2010 China Synthesis Polypeptide Drug Top10 Manufacturers Sales Revenue (100 Million
RMB) 168
Figure China Synthesis Polypeptide Drug Prices Distribution 169
Figure Use Me-Too Model Developed Polypeptide Drug List 169
Table Novartis Company Information Table (Products Applications Manufacturing Base Location
Capacity Expansion Plan Market Position Contact Information etc 13 Items) 170
Figure Novartis China Market Sales Synthesis Polypeptide Drug--Octreotide Acetate Injection
173
Figure Novartis China Market Sales Synthesis Polypeptide Drug--Somatostatin Acetate for
Injection 173
Figure Novartis China Market Sales Synthesis Polypeptide Drug--salmon Calcitonin Nasal Spray
174
Table 2009-2013 Novartis Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross
Figure 2009-2013 Novartis Synthesis Polypeptide Drug Capacity Production (10K Piece) and
Growth Rate 175
Table Merck Serono Company Information Table (Products Applications Manufacturing Base
Location Capacity Expansion Plan Market Position Contact Information etc 13 Items) 176
Figure Merck Serono Synthesis Polypeptide Drug--Recombinant Human Follitropin Alfa Solution
for Injection 178
Figure Merck Serono Synthesis Polypeptide Drug--Somatostatin for Injection 179
Figure Merck Serono Synthesis Polypeptide Drug--Gonadorelin for Injection 179
Table 2009-2013 Merck Serono Synthesis Polypeptide Drug Production (10K Piece) Cost Price
Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 180
Figure 2009-2013 Merck Serono Synthesis Polypeptide Drug Capacity Production (10K Piece)
and Growth Rate 181
Table Ferring Pharmaceuticals Company Information Table (Products Applications Manufacturing
Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items) 182
Figure Ferring Pharmaceuticals China Market Sales Synthesis Polypeptide Drug--Minirin 183
Figure Ferring Pharmaceuticals China Market Sales Synthesis Polypeptide Drug--Decapeptyl

184
Figure Ferring Pharmaceuticals China Market Sales Synthesis Polypeptide Drug--Pentasa 184
Figure Ferring Pharmaceuticals China Market Sales Synthesis Polypeptide Drug--Glypressin
185
Figure Ferring Pharmaceuticals China Market Sales Synthesis Polypeptide Drug--Octostim 186
Table 2009-2013 Ferring Pharmaceuticals Synthesis Polypeptide Drug Production (10K Piece)
Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 186
Figure 2009-2013 Ferring Pharmaceuticals Synthesis Polypeptide Drug Capacity Production (10K
Piece) and Growth Rate 188
Table Ipsen PHarma Biotech Company Information Table (Products Applications Manufacturing
Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items) 188
Figure Ipsen PHarma Biotech Synthesis Polypeptide Drug--Triptorelin Acetate for Injection 190
Table 2009-2013 Ipsen PHarma Biotech Synthesis Polypeptide Drug Production (10K Piece) Cost
Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 190
Figure 2009-2013 Ipsen PHarma Biotech Synthesis Polypeptide Drug Capacity Production (10K
Table Lilly Company Information Table (Products Applications Manufacturing Base Location
Figure Lilly Some China Listed Synthesis Polypeptide Drug List 194
Table 2009-2013 Lilly Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross
Figure 2009-2013 Lilly Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth
Rate 195
Table Asahi Kasei Company Information Table (Products Applications Manufacturing Base
Figure Asahi Kasei Synthesis Polypeptide Drug--Elcatonin Injection 198
Table 2009-2013 Asahi Kasei Synthesis Polypeptide Drug Production (10K Piece) Cost Price
Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 198
Figure 2009-2013 Asahi Kasei Synthesis Polypeptide Drug Capacity Production (10K Piece) and
Growth Rate 199
Table AstraZeneca Company Information Table (Products Applications Manufacturing Base
Figure AstraZeneca China Selling Synthesis Polypeptide Drug—Goserelin Acetate Slow Release
Implantation Agent 201
Table 2009-2013 Jiangsu AstraZeneca Synthesis Polypeptide Drug Production (10K Piece) Cost
Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 202
Figure 2009-2013 Jiangsu AstraZeneca Synthesis Polypeptide Drug Capacity Production (10K
Table SciClone Pharmaceuticals Company Information Table (Products Applications
Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13
Items) 204
Figure SciClone Pharmaceuticals Synthesis Polypeptide Drug-- Thymopetidum Injection 205

Table 2009-2013 SciClone Pharmaceuticals Synthesis Polypeptide Drug Production (10K Piece)
Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 205
Figure 2009-2013 SciClone Pharmaceuticals Synthesis Polypeptide Drug Capacity Production
(10K Piece) and Growth Rate 206
Table Takeda Company Information Table (Products Applications Manufacturing Base Location
Figure Takeda--Leuprorelin Acetate Microspheres for Injection 208
Table 2009-2013 Takeda Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross
Figure 2009-2013 Takeda Synthesis Polypeptide Drug Capacity Production (10K Piece) and
Growth Rate 209
Table HYBIO Pharmaceutical Co.,Ltd Company Information Table (Products Applications
Items) 210
Figure 2009-2013 HYBIO Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug 211
Table 2009-2013 HYBIO Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Production (10K
Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 213
Figure 2009-2013 HYBIO Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Capacity
Production (10K Piece) and Growth Rate 215
Table Hainan Zhonghe Pharmaceutical Co.,Ltd Company Information Table (Products
Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact
Information etc 13 Items) 216
Figure Hainan Zhonghe Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug 217
Table 2009-2013 Hainan Zhonghe Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Production
(10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 217
Figure 2009-2013 Hainan Zhonghe Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Capacity
Table Sichuan Chengdu Diao Pharmaceutical Group Co.,Ltd Company Information Table
(Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position
Contact Information etc 13 Items) 219
Figure Sichuan Chengdu Diao Pharmaceutical Group Co.,Ltd Synthesis Polypeptide
Drug—Thymalfasin Injection 221
Figure Sichuan Chengdu Diao Pharmaceutical Group Co.,Ltd Synthesis Polypeptide
Drug—Thymopentin Injection 222
Table 2009-2013 Sichuan Chengdu Diao Pharmaceutical Group Co.,Ltd Synthesis Polypeptide
Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross
Margin List 222
Figure 2009-2013 Sichuan Chengdu Diao Pharmaceutical Group Co.,Ltd Synthesis Polypeptide
Drug Capacity Production (10K Piece) and Growth Rate 223
Table Beijing Yingu Century Pharmaceutical Co.,Ltd Company Information Table (Products

Figure Beijing Yingu Century Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug-Salmon
Calcitonin Nasal Spray 225
Figure Beijing Yingu Century Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug-Thymopentin
Injection 226
Table 2009-2013 Beijing Yingu Century Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug
Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin
List 226
Figure 2009-2013 Beijing Yingu Century Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug
Capacity Production (10K Piece) and Growth Rate 227
Table Hainan Shuangcheng Pharmaceuticals Co.,Ltd Company Information Table (Products
Figure Hainan Shuangcheng Pharmaceuticals Co.,Ltd Synthesis Polypeptide Drug--Thymalfasin
Injection 229
Figure Hainan Shuangcheng Pharmaceuticals Co.,Ltd Synthesis Polypeptide Drug—Somatostatin
for Injection 231
Figure Hainan Shuangcheng Pharmaceuticals Co.,Ltd Synthesis Polypeptide Drug—Thymopentin
Injection 232
Table 2009-2013 Hainan Shuangcheng Pharmaceuticals Co.,Ltd Synthesis Polypeptide Drug
List 233
Figure 2009-2013 Hainan Shuangcheng Pharmaceuticals Co.,Ltd Synthesis Polypeptide Drug
Table Livzon Pharmaceuticals Co.,Ltd Company Information Table (Products Applications
Items) 234
Figure Livzon Pharmaceuticals Co.,Ltd Synthesis Polypeptide Drug 236
Table 2009-2013 Livzon Pharmaceuticals Co.,Ltd Synthesis Polypeptide Drug Production (10K
Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 236
Figure 2009-2013 Livzon Pharmaceuticals Co.,Ltd Synthesis Polypeptide Drug Capacity
Table Wuhan Hualong Bio-Chemical Pharmaceutical Co.,Ltd Company Information Table
(Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position
Contact Information etc 13 Items) 239
Figure Wuhan Hualong Bio-Chemical Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug--
Thymopentin Injection 240
Figure Wuhan Hualong Bio-Chemical Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug--
Somatostatin for Injection 240
Table 2009-2013 Wuhan Hualong Bio-Chemical Pharmaceutical Co.,Ltd Synthesis Polypeptide
Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross
Margin List 241
Figure 2009-2013 Wuhan Hualong Bio-Chemical Pharmaceutical Co.,Ltd Synthesis Polypeptide

Drug Capacity Production (10K Piece) and Growth Rate 242
Table Chengdu Tiantaishan Pharmaceutical Co.,Ltd Company Information Table (Products
Figure Chengdu Tiantaishan Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug—Somatostatin
for Injection 244
Figure Chengdu Tiantaishan Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug—Thymopentin
Injection 246
Figure Chengdu Tiantaishan Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug—Octreotide
Acetate Injection 247
Table 2009-2013 Chengdu Tiantaishan Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug
List 248
Figure 2009-2013 Chengdu Tiantaishan Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug
Table Beijing Shuanglu Pharmaceutical Co.,Ltd Company Information Table (Products
Figure Beijing Shuanglu Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug-Thymopentin
Injection 251
Figure Beijing Shuanglu Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug-Salmon Calcitonin
Injection 252
Table Beijing Shuanglu Pharmaceutical Co.,Ltd Thymopentin Injection Price List 253
Table 2009-2013 Beijing Shuanglu Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug
List 256
Figure 2009-2013 Beijing Shuanglu Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Capacity
Table Yangzijiang Pharmaceutical Co.,Ltd Company Information Table (Products Applications
Items) 257
Figure Yangzijiang Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug-Somatostatin for
Injection 259
Figure Yangzijiang Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug-Thymopentin Injection
260
Table 2009-2013 Yangzijiang Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Production
(10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 260
Figure 2009-2013 Yangzijiang Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Capacity
Table Changzhou Siyao Pharmaceutical Co.,Ltd Company Information Table (Products

Figure Changzhou Siyao Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug List 264
Table Changzhou Siyao Pharmaceutical Co.,Ltd Chemical Pharmaceutical Raw Materials List
264
Table Changzhou Siyao Pharmaceutical Co.,Ltd Chemical Raw Materials Intermediates List 265
Table 2009-2013 Changzhou Siyao Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug
List 266
Figure 2009-2013 Changzhou Siyao Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Capacity
Table Synthesis Polypeptide Drug Project Key Equipments and Price (10K RMB) 269
Table Synthesis Polypeptide Drug Project Equipments List and Price (10K RMB) 270
Table Drugs Manufacturing Enterprise Specialized Academic Promotion Organization Frame
276
Figure Synthesis Polypeptide Drug Industry Entry Barriers List 293
Table 2012 China Synthesis Polypeptide Drug New Project SWOT Analysis 300
Table 2012 China Synthesis Polypeptide Drug New Project Buildings List 302
Table 2012 China Synthesis Polypeptide Drug New Project Investments (10K RMB) List 303
Table Synthesis Polypeptide Drug New Project Investment Return and Feasibility Analysis 304

Contact: sales@reportsandreports.com for more information.

2012 Deep Research Report on Global and China Synthesis Polypeptide Drug Industry

Empfohlen

Empfohlen

Weitere ähnliche Inhalte

Was ist angesagt?

Was ist angesagt? (19)

Andere mochten auch

Andere mochten auch (13)

Ähnlich wie 2012 Deep Research Report on Global and China Synthesis Polypeptide Drug Industry

Ähnlich wie 2012 Deep Research Report on Global and China Synthesis Polypeptide Drug Industry (20)

2012 Deep Research Report on Global and China Synthesis Polypeptide Drug Industry